GBS Venture Partners (GBS) is a leading health care venture capital fund manager that invests in young businesses developing and commercializing products, which when combined with the right management and finance, will make a significant difference to patients’ lives and deliver superior financial returns for GBS investors. Areas of interest and expertise include biological or small molecule therapeutics, medical devices, and diagnostic systems. GBS invests in private or public companies, whether at startup or later stages of company development.
Maverick Capital is a global investment firm with offices in New York, San Francisco, London, Hong Kong, Philadelphia, and Dallas. With over $11 billion in assets under management, Maverick’s 50-person investment team seeks to grow and preserve capital for its investors, primarily through a long/short-hedged equity strategy. Since the Firm’s inception in 1993, Maverick has strategically invested in private companies that represent disruptive business models or technologies. Maverick actively partners with portfolio company teams through the deployment of its resources and deep fundamental research capabilities to help entrepreneurs build their businesses.
ONSET Ventures helps entrepreneurs transform great ideas into successful businesses. They invest in information technology and medical markets, leveraging both disruptive technologies and disruptive business models. In information technology, they focus on mobility, new media, and infrastructure software. Within medical technology, ONSET focuses on medical devices, drug delivery, diagnostics, and healthcare information technology.
Arboretum Ventures is an early-stage venture capital firm specializing in the healthcare sector. They invest throughout the United States, with a special interest in the Midwest. More than simply a financial resource, Arboretum is a collaborative, value-added investor actively engaging its companies in strategy, operations, recruiting, fundraising, and exit planning. Arboretum aims to transform young companies into mature and thriving businesses that improve patient outcomes and lower the cost of care, thereby generating superior returns for the entrepreneurs and investors.
Affinity Capital Management works with innovative and visionary companies and entrepreneurs to create groundbreaking improvements in health care. From exciting new devices and treatments for improved and cost-effective care to more efficient and affordable technology systems, Affinity helps to create extraordinary value in health care. Affinity has invested in companies in all phases of development—from startups seeking seed capital to growing companies looking to expand their market opportunity.
WRF Capital is the venture investment arm of Washington Research Foundation. A leading early-stage investor, they partner with entrepreneurs, local universities, research institutions, and other investors to develop technology-based startup companies. WRF is a long-term investor that works diligently to help their companies succeed, earning a positive reputation as experienced, trusted partners. WRF seeks to generate outstanding returns through investment activities.